Paolo Gontero

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

Morgan Rouprêt, Marko Babjuk, Maximilian Burger et al. · European Urology · 2020 · 941 citations · Full text

Medicine, Oncology, Urology +16

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

Samantha Cambier, Richard Sylvester, Laurence Collette et al. · European Urology · 2015 · 640 citations · Full text

Medicine, Oncology, Urology +12

Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

Jorg R. Oddens, Maurizio Brausi, Richard Sylvester et al. · European Urology · 2012 · 512 citations

Medicine, Oncology, Urology +8

An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer

George van Andel, Andrew Bottomley, Sophie D. Fosså et al. · European Journal of Cancer · 2008 · 485 citations

Medicine, Oncology, Urology +15

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

Richard Sylvester, Óscar Rodríguez, Virginia Hernández et al. · European Urology · 2021 · 463 citations

Medicine, Oncology, Urology +10